Anti-Human/Mouse/Rat XIAP Antibody [B641]
Anti-Human/Mouse/Rat XIAP Antibody [B641] with collaborator-tested evidence for WB, IF/ICC, ELISA. Read more ›
["WBProduct Description
XIAP is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human, Mouse, Rat; host: Rabbit; clonality: Monoclonal; clone: B641; isotype: IgG,κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IF, ELISA. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human XIAP protein; purification: Protein A; concentration: 0.2 mg/mL.
Database references: UniProt: P98170.
Research Use Only.
Key Facts
| Target | XIAP |
| Also known as | ILP, XLP, API, BIRC, Inhibitor of apoptosis protein, Baculoviral IAP repeat-containing protein, IAP, XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3, X-linked inhibitor of apoptosis, Baculoviral IAP repeat-containing protein 4, E3 ubiquitin-protein ligase XIAP, IAP-like protein, Inhibitor of apoptosis protein 3, RING-type E3 ubiquitin transferase XIAP, X-linked inhibitor of apoptosis protein, IAP3 |
| Concentration | 0.2 mg/mL |
| Species reactivity | Human, Mouse, Rat |
| Observed band | 57 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Cell Biology, Cancer, Metabolism |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | ELISA | |
|---|---|---|---|---|---|---|---|---|
| Human | ||||||||
| Mouse | ||||||||
| Rat |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.